Table 2.
Antimicrobial results of TDN and commercial TiO2 NPs at different concentrations against different microorganisms.
Microorganism: | Escherichia coli | Staphylococcus aureus | Listeria innocua | |||
---|---|---|---|---|---|---|
TDN (µg/mL) | Cel. conc. (cfu/mL) | Log Reduction | Cel. conc. (cfu /mL) | Log Reduction | Cel. conc. (cfu /mL) | Log Reduction |
0 | (3.95 ± 0.16) × 105 | 0 a | (2.02 ± 0.12) × 105 | 0 a | (5.93 ± 0.38) × 105 | 0 a |
100 | (5.36 ± 0.29) × 104 | 0.87 ± 0.02 b | (3.14 ± 0.34) × 104 | 0.81 ± 0.04 b | (1.01 ± 0.63) × 105 | 0.84 ± 0.26 b |
150 | (8.67 ± 0.47) × 102 | 2.66 ± 0.03 e | (1.27 ± 0.28) × 104 | 1.21 ± 0.08 c | (4.46 ± 0.25) × 104 | 1.12 ± 0.02 c |
200 | 0 | 5.59 g | (1.32 ± 0.22) × 103 | 2.19 ± 0.06 d | (4.20 ± 0.27) × 104 | 1.15 ± 0.02 c,d |
400 | 0 | 5.59 g | (5.33 ± 0.23) × 102 | 2.58 ± 0.02 e | (5.05 ± 0.07) × 103 | 2.07 ± 0.01 f |
TiO2 NPs (µg/mL) | Cel. conc. (cfu /mL) | Log Reduction | Cel. conc. (cfu /mL) | Log Reduction | Cel. conc. (cfu /mL) | Log Reduction |
0 | (4.58 ± 1.52) × 105 | 0 a | (1.98 ± 0.29) × 105 | 0 a | (3.57 ± 0.48) × 105 | 0 a |
100 | (5.42 ± 0.45) × 103 | 1.93 ± 0.04 c | (2.75 ± 0.19) × 102 | 2.86 ± 0.02 f | (1.42 ± 0.21) × 104 | 1.40 ± 0.05 e |
150 | (2.77 ± 0.48) × 103 | 2.22 ± 0.08 d | (1.67 ± 0.89) × 102 | 3.12 ± 0.21 g | (1.63 ± 0.65) × 104 | 1.37 ± 0.15 d,e |
200 | (5.17 ± 0.88) × 102 | 2.95 ± 0.07 f | 0 | 5.36 h | (1.03 ± 0.12) × 103 | 2.54 ± 0.04 g |
400 | 0 | 5.66 g | 0 | 5.36 h | (7.17 ± 0.95) × 102 | 2.69 ± 0.05 g |
a–h Means values within a column with different superscripts differ significantly (p < 0.05).